CLEC1B and hepatocellular carcinoma: For instance, higher expression of CLEC1B and FCN3 significantly associated with the good outcome of HCC patients in TCGA-LIHC cohort; while higher expression of PRC1 is significantly associated with the poor outcome of HCC patients in both TCGA-LIHC and GSE14520 cohorts.